Advancements in AML & MDS: Genetic Sequencing & Immune Therapies | David Swoboda, MD | ASCO 2023

Advancements in AML & MDS: Genetic Sequencing & Immune Therapies | David Swoboda, MD | ASCO 2023
LINKER-MM1 Study: Linvoseltamab (REGN5458) in Relapsed/Refractory Myeloma | Hans Lee, MD | ASCO 2023
ASCO 2023 Highlights To Look Forward To | Saad Usmani, MD | ASCO 2023
(Guest Lecture): The History of Myeloma with Dr. Craig Cole